MedPath

MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey

Conditions
Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance
Smoldering Multiple Myeloma
Coronavirus
Registration Number
NCT04727294
Lead Sponsor
HealthTree Foundation
Brief Summary

The purpose of this study is to examine how patients with multiple myeloma (MM) have been impacted by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

The study will use a questionnaire to further understand how patients are being affected and gather information in order to track the long-term effects of the coronavirus.

The scope of the questionnaire will include, COVID-19 diagnosis and treatment, changes in myeloma treatment and care, clinical trial familiarity, health and fitness, and quality of life.

This questionnaire is a follow-on to the "MM and COVID-19" questionnaire.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • Adult patients (greater than 18 years) diagnosed with MGUS, smoldering myeloma, and multiple myeloma.
  • Access to a computer or electronic device with internet access, or phone
  • Willing to create a patient profile on the HealthTree Cure Hub For Multiple Myeloma
  • Willing to give electronically-signed consent
  • Ability to read questions in English
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of Life (QOL) Distress Screening toolUp to one year

Describe how patients rate their level of concern on psychosocial, practical, and physical needs during the COVID-19 pandemic using the Cancer Support Community's CancerSupportSource distress screening tool.

COVID-19 Diagnosis and TreatmentUp to one year

Describe how patients diagnosed with COVID-19 were treated for the virus.

Changes to Myeloma Treatment and CareUp to one year

Describe which treatments were changed and how care was affected as a result of COVID-19

Health and FitnessUp to one year

Describe how COVID-19 impacted patient's health and fitness

Secondary Outcome Measures
NameTimeMethod
Clinical Trial FamiliarityUpon enrollment

Describe how familiar patients are with multiple myeloma clinical trials.

Trial Locations

Locations (1)

HealthTree.org (Online)

🇺🇸

Lehi, Utah, United States

HealthTree.org (Online)
🇺🇸Lehi, Utah, United States
Nathan Sweeney, PhD
Contact
800-709-1113
nathan@healthtree.org
Ana Sahagun, MS
Contact
1-800-709-1113

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.